Back to Search
VASSILIKI BOUSSIOTIS, MD PHD
MD PHD
Hematology & Oncology Physician
NPI: 1861474215IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
220011(MA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
220011(MA)
Education
OTHER
Class of 1980
Research & Publications (20)
Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease.
PMID 11154238·Blood·2001
7-preclinical
IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.
PMID 10792007·J Clin Invest·2000
8-other
p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes.
PMID 10700231·Nat Med·2000
7-preclinical
The cyclin dependent kinase inhibitor (R)-roscovitine prevents alloreactive T cell clonal expansion and protects against acute GvHD.
PMID 19448431·Cell Cycle·2009
7-preclinical
Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.
PMID 18596736·Leukemia·2009
8-other
Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression.
PMID 19270514·Cell Cycle·2009
6-review
Control and regulation of peripheral tolerance in allergic inflammatory disease: therapeutic consequences.
PMID 18802347·Chem Immunol Allergy·2008
6-review
CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.
PMID 18410894·Biol Blood Marrow Transplant·2008
8-other
Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy.
PMID 18292287·Blood·2008
8-other
Targeting the follicular lymphoma microenvironment through blockade of TNFalpha with etanercept.
PMID 18464109·Leuk Lymphoma·2008
3-trial
Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3.
PMID 18573917·J Cell Biol·2008
7-preclinical
Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.
PMID 18395491·Clin Immunol·2008
6-review
The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells.
PMID 19073936·Proc Natl Acad Sci U S A·2008
7-preclinical
Active Rap1, a small GTPase that induces malignant transformation of hematopoietic progenitors, localizes in the nucleus and regulates protein expression.
PMID 17487743·Leuk Lymphoma·2007
7-preclinical
Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytes.
PMID 17164348·Blood·2007
8-other
Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo.
PMID 17448912·Biol Blood Marrow Transplant·2007
7-preclinical
Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications.
PMID 16972086·J Mol Med (Berl)·2006
6-review
Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3.
PMID 16979556·Curr Biol·2006
7-preclinical
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
PMID 17013388·Nat Immunol·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 BLOSSOM ST, HEMATOLOGY ONCOLOGY ASSOCIATES COX 2
BOSTON, MA 02114 - Phone
- (617) 724-3200
Quick Facts
- NPI
- 1861474215
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile